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Abstract: Statistical methods for analyzing large-scale biomolecular data
are commonplace in computational biology. A notable example is pheno-
type prediction from gene expression data, for instance detecting human
cancers, differentiating subtypes, and predicting clinical outcomes. Still,
clinical applications remain scarce. One reason is that the complexity of the
decision rules that emerge from standard statistical learning impedes bio-
logical understanding, in particular any mechanistic interpretation. Here we
explore decision rules for binary classification utilizing only the ordering of
expression among several genes; the basic building blocks are then two-gene
expression comparisons. The simplest example, just one comparison, is the
TSP classifier, which has appeared in a variety of cancer-related discovery
studies. Decision rules based on multiple comparisons can better accommo-
date class heterogeneity and thereby increase accuracy, and might provide
a link with biological mechanism. We consider a general framework (“rank-
in-context”) for designing discriminant functions, including a data-driven
selection of the number and identity of the genes in the support (“con-
text”). We then specialize to two examples: voting among several pairs and
comparing the median expression in two groups of genes. Comprehensive
experiments assess accuracy relative to other, more complex, methods, and
reinforce earlier observations that simple classifiers are competitive.
Keywords and phrases: Cancer classification, Gene expression, Rank
discriminant, Order statistics.
1. Introduction
Statistical methods for analyzing high-dimensional biomolecular data generated
with high-throughput technologies permeate the literature in computational bi-
ology. Prominent examples are genome-wide association studies based on DNA
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sequence data, and gene network inference and genotype-to-phenotype predic-
tion based on gene microarray data. Such analyses have uncovered a great deal
of information about biological processes, such as important mutations and lists
of “marker genes” associated with common diseases (Jones et al. [2008], Thomas
et al. [2007]) and key interactions in transcriptional regulation (Auffray [2007],
Lee et al. [2008]).
The work here is about learning classifiers that can distinguish between cel-
lular phenotypes from mRNA transcript levels collected from cells in assayed
tissue. The primary focus is the structure of the prediction rules. This is largely
motivated by applications involving genetic diseases such as cancer, where ma-
lignant phenotypes arise from the net effect of interactions among multiple genes
and other molecular agents within biological networks. Moreover, the resulting
perturbations in signaling pathways can be detected and quantified with mRNA
counts estimated from microarrays. In principle, therefore, statistical methods
can enhance our understanding by detecting the presence of disease (e.g., “tu-
mor” vs “normal”), discriminating among cancer sub-types (e.g., “GIST” vs
“LMS” or “BRCA1 mutation” vs “no BRCA1 mutation”) and predicting clini-
cal outcomes (e.g., “poor prognosis” vs “good prognosis”).
Nonetheless, the applications to biomedicine, specifically the implications for
clinical practice, are widely acknowledged to remain limited; see Altman et al.
[2011], Marshall [2011], Evans et al. [2011] and the discussion in Winslow et al.
[2012]. One barrier is the study-to-study diversity in reported prediction accu-
racies and “signatures” (lists of discriminating genes). Some of this variation
can be attributed to the over-fitting that results from the unfavorable ratio of
the sample size to the number of potential biomarkers, i.e., the infamous “small
n, large d” dilemma. Typically, the number of samples (chips, profiles, patients)
per class is n = 10 − 1000 whereas the number of features (exons, transcripts,
genes) is usually d = 1000 − 50, 000; Table 1 displays n0, n1, d for twenty-one
publicly available datasets involving two phenotypes.
However, complex decision rules are perhaps the central obstacle to mature
applications. The classification methods applied to biological data were usually
designed for other purposes, such as improving statistical learning or appli-
cations to vision and speech, with little emphasis on transparency. Specifically,
the rules generated by nearly all standard, off-the-shelf techniques applied to ge-
nomics data, such as neural networks (Bicciato et al. [2003], Bloom et al. [2004],
Khan et al. [2001]), multiple decision trees (Boulesteix et al. [2003], Zhang et al.
[2003]), support vector machines (Peng et al. [2003], Yeang et al. [2001]), boost-
ing (Qu et al. [2002], Dettling and Buhlmann [2003]), and linear discriminant
analysis (Guo et al. [2007], Tibshirani et al. [2002]), usually involve nonlinear
functions of hundreds or thousands of genes, a great many parameters, and are
therefore too complex to characterize biologically.
In contrast, follow-up studies, for instance independent validation or thera-
peutic development, are usually based on a relatively small number of biomark-
ers whose concentrations can then be assayed with high-resolution methods
such as RT-PCR. This usually also requires an understanding of the role of
the genes and gene products in the context of molecular pathways. Ideally,
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Table 1
The Datasets: Twenty-one datasets involving two disease-related phenotypes (e.g., cancer vs
normal tissue or two cancer sub-types), illustrating the “small n, large d” situation. Shown
are the samples sizes for the two classes and the number d of features (probes on the
microarray). The more pathological phenotype is labeled as Class 1 when this information is
available.
Study Class 0 (size) Class 1 (size) Probes d Reference
D1 Colon Normal (22) Tumor (40) 2000 Alon et al. [1999]
D2 BRCA1 non-BRCA1 (93) BRCA1 (25) 1658 Lin et al. [2009]
D3 CNS Classic (25) Desmoplastic (9) 7129 Pomeroy et al. [2002]
D4 DLBCL DLBCL (58) FL (19) 7129 Shipp et al. [2002]
D5 Lung Mesothelioma (150) ADCS (31) 12533 Gordon et al. [2002]
D6 Marfan Normal (41) Marfan (60) 4123 Yao et al. [2007]
D7 Crohn’s Normal (42) Crohn’s (59) 22283 Burczynski et al. [2006]
D8 Sarcoma GIST (37) LMS (31) 43931 Price et al. [2007]
D9 Squamous Normal (22) Head-Neck Cancer (22) 12625 Kuriakose et al. [2004]
D10 GCM Normal (90) Tumor (190) 16063 Ramaswamy et al. [2001]
D11 Leukemia 1 ALL (25) AML (47) 7129 Golub et al. [1999]
D12 Leukemia 2 AML1 (24) AML2 (24) 12564 Armstrong et al. [2002]
D13 Leukemia 3 ALL(710) AML (501) 19896 Kohlmann et al. [2008]
D14 Leukemia 4 Normal (138) AML (403) 19896 Mills et al. [2009]
D15 Prostate 1 Normal (50) Tumor (52) 12600 Singh et al. [2002]
D16 Prostate 2 Normal (38) Tumor (50) 12625 Stuart et al. [2004]
D17 Prostate 3 Normal (9) Tumor (24) 12626 Welsh et al. [2001]
D18 Prostate 4 Normal (25) Primary (65) 12619 Yao et al. [2004]
D19 Prostate 5 Primary (25) Metastatic (65) 12558 Yao et al. [2004]
D20 Breast 1 ER-positive (61) ER-negative(36) 16278 Enerly et al. [2011]
D21 Breast 2 ER-positive(127) ER-negative(80) 9760 Buffa et al. [2011]
the decision rules could be interpreted mechanistically, for instance in terms of
transcriptional regulation, and be robust with respect to parameter settings.
Consequently, what is notably missing from the large body of work applying
classification methodology to computational genomics is a solid link with po-
tential mechanism, which seem to be a necessary condition for “translational
medicine” (Winslow et al. [2012]) i.e., drug development and clinical diagnosis.
Needless to say, accuracy is also necessary, but the accuracy of many of the
methods mentioned above is already high enough to be of potential clinical value
for many important phenotype distinctions. And whereas it has become com-
monplace to follow methodological development and illustrations on real data
with a discussion of the genes appearing in the support (“signature”) of the
classifier, often in terms of their “enrichment” for specific biological process and
molecular functions, this does not substitute for providing a potential mecha-
nistic characterization of the decision rules in terms of biochemical interactions
or specific regulatory motifs.
These translational objectives, and small-sample issues, argue for limiting
the number of parameters and introducing strong biases. The two principal
objectives for the family of classifiers described here are:
• Use elementary and parameter-free building blocks to assemble a classifier
which is determined by its support.
• Demonstrate that these can be as discriminating as those that emerge
from the most powerful methods in statistical learning.
The building blocks we choose are two-gene comparisons, which we think
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of as “biological switches” which can be directly related to regulatory “mo-
tifs” or other properties of transcriptional networks. The decision rules are then
determined by expression orderings. However, explicitly connecting statistical
classification and molecular mechanism for particular diseases is a major chal-
lenge and is well beyond the scope of this paper; by our construction we are
anticipating our longer-term goal of incorporating mechanism, and some com-
ments on the relationship between comparisons and regulation appear in the
concluding section.
As concerns our second objective, we measure the performance of our comparison-
based classifiers relative to two popular alternatives, namely support vector
machines and PAM (Tibshirani et al. [2002]), a variant of linear discriminant
analysis, where the “metric” chosen is the estimated error in multiple runs of
ten-fold cross validation for each of the twenty-one real datasets in Table 1.
Whereas a comprehensive simulation study could be conducted, for example
along the lines of those in Guo et al. [2005], Zhang et al. [2006] and Fan and
Fan [2008] based on Gaussian models of microarray data, our intention is differ-
ent: show that even when the number of parameters is small, in fact the decision
rule is determiend by the support, the accuracy in cross-validation on real data
is no worse than with currently available classifiers.
More precisely, all the classifiers studied in this paper are based on a gen-
eral rank discriminant g(X; Θ), a real-valued function on the ranks of X over
a (possibly ordered) subset of genes Θ, called the context of the classifier. We
are searching for characteristic perturbations in this ordering from one pheno-
type to another. The TSP classifier is the simplest example (see Section 2),
and the decision rule is illustrated in Figure 1. This data set has expression
profiles for two kinds of gastrointestinal cancer (gastrointestinal stromal-GIST,
leiomyosarcoma-LMS) which are difficult to distinguish clinically but require
very different treatments (Price et al. [2007]). Each point on the x-axis corre-
sponds to a sample, and the vertical dashed line separates the two phenotypes.
The y-axis represents expression; as seen, the “reversal” of the ordering of the
expressions of the two genes identifies the phenotype except in two samples.
Evidently, a great deal of information may be lost by converting to ranks,
particularly if the expression values are high resolution. But there are techni-
cal advantages to basing prediction on ranks, including reducing study-to-study
variations due to data normalization and pre-processing; for example, rank-
based methods are evidently invariant to general monotone transformations of
the original expression values, such as the widely-used quantile normalization
(Bloated et al. [2004]). This enables combining inter-study microarray data with-
out the need to perform data normalization, thereby increasing sample size.
However, our principal motivation is complexity reduction: severely limiting
the number of variables and parameters, and in fact introducing what we call
rank-in-context (RIC) discriminants which depend on the training data only
through the context. The classifier f is then defined by thresholding g. This
implies that, given a context Θ, the RIC classifier corresponds to a fixed deci-
sion boundary, in the sense that it does not depend on the training data. This
sufficiency property helps to reduce variance by rendering the classifiers rela-
B. Afsari, U. Braga-Neto, D. Geman/Rank Discriminants 5
tively insensitive to small disturbances to the ranks of the training data and
is therefore especially suitable to small-sample settings. Naturally, the perfor-
mance critically depends on the appropriate choice of Θ. We propose a simple
yet powerful procedure to select Θ from the training data, partly inspired by
the principle of analysis of variance and involving the sample means and sample
variances of the empirical distribution of g under the two classes. In particular,
we do not base the choice directly on minimizing error.
We consider two examples of the general framework. The first is a new method
for learning the context of KTSP, a previous extension of TSP to a variable
number of pairs. The decision rule of the KTSP classifier is the majority vote
among the top k pairs of genes, illustrated in Figure 1 for k = 10 for the same
dataset as above. In previous statistical and applied work (Tan et al. [2005]),
the parameter K (the number of comparisons) was determined by an inner loop
of cross-validation, which is subject to over-fitting with small samples. We also
propose comparing the median of expression between two sets of genes; this
Top-Scoring Median (TSM) rule is also illustrated in Figure 1; as can be seen,
the difference of the medians generally has a larger “margin” than in the special
case of singleton sets, i.e., TSP. A summary of all the methods is given in Table
2.
After reviewing related work in the following section, in Section 3 we present
the classification scenario, propose our general statistical framework, and focus
on two examples: KTSP and TSM. The experimental results are in Section 4,
where comparisons are drawn, and we conclude with some discussion about the
underlying biology in Section 5.
2. Previous and Related Work
Our work builds on previous studies analyzing transcriptomic data solely based
on relative expression, more precisely the orderings among the expressions of a
small number of transcripts. This methodology was designed to promote invari-
ance to data normalization and transparency of the decision rules. The simplest
example, the Top-Scoring Pair (TSP) classifier, was introduced in Geman et al.
[2004] and is based on two genes. Various extensions and illustrations appeared
in Xu et al. [2005], Lin et al. [2009], Tan et al. [2005]. Applications to pheno-
type classification include differentiating between stomach cancers (Price et al.
[2007]), predicting treatment response in breast cancer (Weichselbaum et al.
[2008]) and acute myeloid leukemia (Raponi et al. [2008]), detecting BRCA1
mutations (Lin et al. [2009]), grading prostate cancers (Zhao et al. [2010]), and
separating diverse human pathologies assayed through blood-borne leukocytes
(Edelman et al. [2009]).
In Geman et al. [2004] and subsequent papers about TSP, the discriminating
power of each pair of genes i, j was measured by the absolute difference between
the probabilities of the event that gene i is expressed more than gene j in the
two classes. These probabilities were estimated from training data and (binary)
classification resulted from voting among all top-scoring pairs. In Xu et al.
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Fig 1. Results of three rank-based classifiers for differentiating two cancer subtypes, GIST
and LMS. The training set consists of 37 GIST samples and 31 LMS samples (separated by
the vertical dashed line); each sample provides measurements for 43, 931 transcripts. TSP:
Expression values for the two genes selected by the TSP algorithm. KTSP: The number of
votes for each class among the K = 10 pairs of genes selected by KTSP algorithm. TSM:
Median expressions of two sets of genes selected by the TSM algorithm.
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[2005] a secondary score was introduced which provides a unique top-scoring
pair. In addition, voting was extended to the k highest-scoring pairs of genes.
The motivation for this KTSP classifier and other extensions (Tan et al. [2005],
Anderson et al. [2007], Xu et al. [2007]) is that more genes may be needed to
detect cancer pathogenesis, especially if the principle objective is to characterize
as well as recognize the process. Finally, in a precursor to the work here (Xu et al.
[2007]), the two genes in TSP were replaced by two equally-sized sets of genes
and the average ranks were compared. Since the direct extension of TSP score
maximization was computationally impossible, and likely to badly over-fit the
data, the sets were selected by splitting top-scoring pairs and repeated random
sampling. Although ad hoc, this further demonstrated the discriminating power
of rank statistics for microarray data.
Finally, there is some related work about ratios of concentrations (which
are natural in chemical terms) for diagnosis and prognosis, That work is not
rank-based but retains invariance to scaling. Golub et al. [1999] distinguished
between malignant pleural mesothelioma (MPM) and adenocarcinoma (ADCA)
of the lung by combining multiple ratios into a single diagnostic tool, and Ma
et al. [2004] found that a two-gene expression ratio derived from a genome-
wide, oligonucleotide microarray analysis of estrogen receptor (ER)-positive,
invasive breast cancers predicts tumor relapse and survival in patients treated
with tamoxifen, which is crucial for early-stage breast cancer management.
3. Rank-In-Context Classification
In this section, we introduce a general framework for rank-based classifiers using
comparisons among a limited number of gene expressions, called the context. In
addition, we describe a general method to select the context, which is inspired
by the analysis of variance paradigm of classical statistics. These classifiers have
the property that they depend on the sample data solely through the context
selection; in other words, given the context, the classifiers have a fixed decision
boundary and do not depend on the training data. For example, as will be seen
in later sections, the Top-Scoring Pair (TSP) classifier is RIC. Once a pair of
genes (i.e., the context) is specified, the TSP decision boundary is fixed, and
corresponds to a 45-degree line going through the origin in the feature space
defined by the two genes. This confers to RIC classifiers a minimal-training
property, which makes them insensitive to small disturbances to the ranks of
the training data, reducing variance and overfitting, and rendering them espe-
cially suitable to small-sample settings. We will demonstrate the general RIC
framework with two specific examples, namely the previously introduced KTSP
classifier based on majority voting among comparisons (Tan et al. [2005]), as
well as a new classifier based on the comparison of the medians, the Top-Scoring
Medians (TSM) classifier.
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3.1. RIC Discriminant
Let X = (X1, X2, . . . , Xd) denote the expression values of d genes on an expres-
sion microarray. Our objective is to use X to distinguish between two conditions
or phenotypes for the cells in the assayed tissue, denoted Y = 0 and Y = 1.
A classifier f associates a label f(X) ∈ {0, 1} with a given expression vector
X. Practical classifiers are inferred from training data, consisting of i.i.d. pairs
Sn = {(X(1), Y (1)), . . . , (X(n), Y (n))}.
The classifiers we consider in this paper are all defined in terms of a gen-
eral rank-in-context discriminant g(X; Θ(Sn)), which is defined as a real-valued
function on the ranks of X over a subset of genes Θ(Sn) ⊂ {1, . . . , d}, which is
determined by the training data Sn and is called the context of the classifier (the
order of indices in the context may matter). Such discriminants are called rank-
in-context because they depend on the training data only through the context.
The corresponding RIC classifier f is defined by
f(X; Θ(Sn)) = I(g(X; Θ(Sn)) > t) =
{
1 , g(X; Θ(Sn)) > t
0 , otherwise ,
(3.1)
where I(E) denotes the indicator variable of event E. The threshold parameter
t can be adjusted to achieve a desired specificity and sensitivity (see Section 3.4
below); otherwise, one usually sets t = 0. For simplicity we will write henceforth
Θ instead of Θ(Sn), with the implicit understanding that in RIC classification
Θ is selected from the training data Sn.
We will consider in this section two families of RIC classifiers. The first ex-
ample is the k-Top Scoring Pairs (KTSP) classifier, which is a majority voting
rule among k pairs of genes (Tan et al. [2005]); KTSP was the winning entry of
the International Conference in Machine Learning and Applications (ICMLA)
2008 challenge for micro-array classification (Geman et al. [2008]). Here, the
context is partitioned into a set of gene pairs Θ = {(i1, j1), . . . , (ik, jk)}, where
k is a positive odd integer, in such a way that all pairs are disjoint, i.e., all 2k
genes are distinct. The RIC discriminant is given by:
gKTSP(X; (i1, j1), . . . , (ik, jk)) =
k∑
r=1
[
I(Xir < Xjr )−
1
2
]
. (3.2)
This KTSP RIC discriminant simple counts positive and negative “votes” in
favor of ascending or descending ranks, respectively. The KTSP classifier is
given by (3.1), with t = 0, which yields
fKTSP(X; (i1, j1), . . . , (ik, jk)) = I
(
k∑
r=1
I(Xir < Xjr ) >
k
2
)
. (3.3)
The KTSP classifier is thus a majority-voting rule: it assigns label 1 to the ex-
pression profile if the number of ascending ranks exceeds the number of descend-
ing ranks in the context. The choice of odd k avoids the possibility of a tie in the
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vote. If k = 1, then the KTSP classifier reduces to fTSP(X; (i, j)) = I(Xi < Xj),
the Top-Scoring Pair (TSP) classifier (Geman et al. [2004]).
The second example of an RIC classifier we propose is the Top Scoring Median
(TSM) classifier, which simply compares the median rank of two sets of genes.
The median rank has the advantage that for any individual sample the median
is the value of one of the genes. Hence, in this sense, a comparison of medians
for a given sample is equivalent to the comparison of two gene expressions, as
in the TSP decision rule. Here, the context is partitioned into two sets of genes,
Θ = {G+k , G−k }, such that |G+k | = |G−k | = k, where k is again a positive odd
integer, and G+k and G
−
k are disjoint, i.e., all 2k genes are distinct. Let Ri be
the rank of Xi in the context Θ = G
+
k ∪ G−k , such that Ri = j if Xi is the
jth smallest value among the gene expression values indexed by Θ. The RIC
discriminant is given by:
gTSM(X;G
+
k , G
−
k ) = med
j∈G+k
Rj − med
i∈G−k
Ri . (3.4)
where “med” denotes the median operator. The TSM classifier is then given by
(3.1), with t = 0, which yields
fTSM(X;G
+
k , G
−
k ) = I
(
med
j∈G+k
Rj > med
i∈G−k
Ri
)
. (3.5)
Therefore, the TSM classifier outputs 1 if the median of ranks in G+k exceeds
the median of ranks in G−k , and 0 otherwise — notice that this is equivalent to
comparing the medians of the raw expression values directly. We remark that
an obvious variation would be to compare the average rank rather than the
median rank — this in fact corresponds to the “TSPG” approach defined in
Xu et al. [2007], except that in that study, the context for TSPG was selected
by splitting a fixed number of TSPs. We observed that the performances of the
mean-rank and median-rank classifiers are similar, with a slight superiority of
the median-rank (data not shown).
3.2. Criterion for Context Selection
The performance of RIC classifiers critically depends on the appropriate choice
of the context Θ ⊂ {1, . . . , d}. We propose a simple yet powerful procedure to
select Θ from the training data Sn. To motivate the proposed criterion, first
note that a necessary condition for the context Θ to yield a good classifier is
that the discriminant g(X; Θ) has sufficiently distinct distributions under Y = 1
and Y = 0. This can be expressed by requiring that the difference between the
expected values of g(X; Θ) between the populations, namely
δ(Θ) = E[g(X; Θ) | Y = 1, Sn]− E[g(X; Θ) | Y = 0, Sn] (3.6)
be maximized. Notice that this maximization is with respect to Θ alone; g is
fixed and chosen a priori. In practice, one employs the maximum-likelihood
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empirical criterion
δˆ(Θ) = Eˆ[g(X; Θ) | Y = 1, Sn]− Eˆ[g(X; Θ) | Y = 0, Sn] , (3.7)
where
Eˆ[g(X; Θ) | Y = c, Sn] =
∑n
i=1 g(X
(i); Θ)I(Y (i) = c)∑n
i=1 I(Y
(i) = c)
, (3.8)
for c = 0, 1.
In the case of KTSP, The criterion in (3.6) becomes
δKTSP((i1, j1), . . . , (ik, jk)) =
k∑
r=1
sirjr (3.9)
where the pairwise score sij for the pair of genes (i, j) is defined as
sij = P (Xi < Xj | Y = 1)− P (Xi < Xj | Y = 0) . (3.10)
Notice that if the pair of random variables (Xi, Xj) has a continuous distribu-
tion, so that P (Xi = Xj) = 0, then we have that sij = −sji. In addition, it
does not matter in this case whether Xi < Xj is replaced by Xi ≤ Xj in sij in
(3.10).
The empirical criterion δˆKTSP((i1, j1), . . . , (ik, jk)) (c.f. Eq 3.7) is obtained
by substituting in (3.9) the empirical pairwise scores
sˆij = Pˆ (Xi < Xj | Y = 1)− Pˆ (Xi < Xj | Y = 0) . (3.11)
Here the empirical probabilities are defined by Pˆ (Xi < Xj | Y = c) = Eˆ[ I(Xi <
Xj) | Y = c ], for c = 0, 1, where the operator Eˆ is defined in (3.8).
For TSM, the criterion in (3.6) is given by
δTSM(G
+
k , G
−
k ) =
E
[
med
j∈G+k
Rj − med
i∈G−k
Ri
∣∣∣∣Y = 1
]
− E
[
med
j∈G+k
Rj − med
i∈G−k
Ri
∣∣∣∣Y = 0
]
.
(3.12)
The following result relates δTSM(G
+
k , G
−
k ) to the pairwise scores sij defined
in (3.10). For notation simplicity, in the following m+ and m− denote the indices
of the genes that achieve the median rank in G+ and G−, respectively.
Proposition 1. Assume that the profile vector X has a probability density,
which follows the following (mild) distributional smoothness conditions
(A1) For each i ∈ G−k , j ∈ G+k , the event {Xi < Xj} is conditionally indepen-
dent from {m− = i} and {m+ = j} given Y .
(A2) The distribution of (m+,m−) is uniform given Y .
Then the criterion (3.12) can be written as
δTSM(G
+
k , G
−
k ) =
2
k
∑
i∈G−k ,j∈G+k
sij , (3.13)
where sij is the pairwise score defined in (3.10).
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Proof. See Appendix.
The difference between the two criteria (3.9) for KTSP and (3.13) for TSM
for selecting the context is that the former involves scores for k expression
comparisons and the latter involves k2 comparisons since each gene i ∈ G−k
is paired with each gene j ∈ G+k . Moreover, using the estimated solution to
maximizing (3.9) (see below) to construct G−k and G
+
k by putting the first gene
from each pair into one and the second gene from each pair into the other
does not work as well in maximizing (3.13) as the algorithms described in the
Appendix.
The distributional smoothness conditions in the previous proposition are jus-
tified if k is not too large. We study this in the Appendix. Finally, the empirical
criterion δˆTSM(G
+
k , G
−
k ) can be calculated by substituting in (3.13) the empirical
pairwise scores sˆij defined in (3.11).
3.3. Maximization of the Criterion
Maximization of (3.6) or (3.7) works well as long as the size of the context |Θ|,
i.e., the number of context genes, is kept fixed. The reason is that the criterion
tends to be monotonically increasing with |Θ|, which complicates selection. We
address this problem by proposing a modified criterion, which is partly inspired
by the principle of analysis of variance in classical Statistics. This modified
criterion penalizes the addition of more genes to the context by requiring that
the variance of g(X; Θ) within the populations be minimized. The latter is given
by
σˆ(Θ) =
√
V̂ar(g(X; Θ) | Y = 0, Sn) + V̂ar(g(X; Θ) | Y = 1, Sn) , (3.14)
where V̂ar is the maximum-likelihood estimator of the variance,
V̂ar(g(X; Θ) | Y = c, Sn)
=
∑n
i=1(g(X
(i); Θ)− Eˆ[g(X; Θ) | Y = c, Sn])2 I(Y (i) = c)∑n
i=1 I(Y
(i) = c)
,
(3.15)
for c = 0, 1. The modified criterion to be maximized is
τˆ(Θ) =
δˆ(Θ)
σˆ(Θ)
, (3.16)
The statistic τˆ(Θ) is reminiscent of the the Welch two-sample t-test statistic of
classical hypothesis testing (Casella and Berger [2002]).
Direct maximization of (3.7) or (3.16) is in general a hard computational
problem for the numbers of genes typically encountered in expression data. We
propose instead a greedy procedure. Assuming that a pre-defined range of values
Ω for the context size |Θ| is given, the procedure is:
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(1) For each value of k ∈ Ω, an optimal context Θ∗k is chosen that maximizes
(3.7) among all contexts Θk containing k genes:
Θ∗k = arg max|Θ|=k
δˆ(Θ) . (3.17)
(2) An optimal value k∗ is chosen that maximizes (3.16) among all contexts
{Θ∗k | k ∈ Ω} obtained in the previous step:
k∗ = arg max
k∈Ω
τˆ(Θ∗k) . (3.18)
For KTSP, the maximization in step (1) of the previous context selection
procedure becomes
{(i∗1, j∗1 ), . . . , (i∗k, j∗k)} = arg max{(i1,j1),...,(ik,jk)} δˆKTSP((i1, j1), . . . , (ik, jk))
= arg max
{(i1,j1),...,(ik,jk)}
k∑
r=1
sˆirjr .
(3.19)
We propose a greedy approach to this maximization problem: initialize the list
with the top scoring pair of genes, then keep adding pairs to the list whose genes
have not appeared so far (ties are broken by the secondary score proposed in Xu
et al. [2005]). This process is repeated until k pairs are chosen. This corresponds
essentially to the same method that was proposed, for fixed k, in the original
paper on KTSP (Tan et al. [2005]). This shows that the previously-proposed
heuristic has a justification in terms of maximizing the separation between the
rank discriminant (3.2) across the classes.
To obtain the optimal value k∗, one applies step (2) of the context selection
procedure, with a range of values k ∈ Ω = {3, 5, . . . ,K}, for odd K (k = 1 can
be added if 1-TSP is considered). Note that here
σˆKTSP(Θ) =
√√√√V̂ar( k∑
r=1
[I(Xi∗r < Xj∗r )] | Y =0
)
+ V̂ar
(
k∑
r=1
[I(Xi∗r < Xj∗r )] | Y =1
)
.
(3.20)
Therefore, the optimal value of k is selected by
k∗ = arg max
k=3,5,...,K
τˆKTSP((i
∗
1, j
∗
1 ), . . . , (i
∗
k, j
∗
k)) (3.21)
where
τˆKTSP((i
∗
1, j
∗
1 ), . . . , (i
∗
k, j
∗
k)) =
δˆKTSP((i
∗
1, j
∗
1 ), . . . , (i
∗
k, j
∗
k))
σˆKTSP((i∗1, j
∗
1 ), . . . , (i
∗
k, j
∗
k))
=
∑k
r=1 sˆi∗rj∗r√
V̂ar
(∑k
r=1[I(Xi∗r < Xj∗r )] | Y =0
)
+ V̂ar
(∑k
r=1[I(Xi∗r < Xj∗r )] | Y =1
) .
(3.22)
Finally, the optimal context is then given by Θ∗ = {(i∗1, j∗1 ), . . . , (i∗k∗ , j∗k∗)}.
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For TSM, The maximization in step (1) of the context selection procedure
can be written as
(G+,∗k , G
−,∗
k ) = arg max
(G+k ,G
−
k )
δˆTSM(G
+
k , G
−
k )
= arg max
(G+k ,G
−
k )
∑
i∈G−k ,j∈G+k
sˆij ,
(3.23)
Finding the global maximum in (3.23) is not feasible in general. We consider
a sub-optimal strategy for accomplishing this task: sequentially construct the
context by adding two genes at a time. Start by selecting the TSP pair i, j and
setting G−1 = {i} and G+1 = {j}. Then select the pair of genes i′, j′ distinct from
i, j such that the sum of scores is maximized by G−2 = {i, i′} and G+2 = {j, j′},
i.e., δˆTSM(G
+
k , G
−
k ) is maximized over all sets G
+
k , G
−
k of size two, assuming
i ∈ G−k and j ∈ G+k . This involves computing three new scores. Proceed in this
way until k pairs have been selected.
To obtain the optimal value k∗, one applies step (2) of the context selection
procedure, with a range of values k ∈ Ω = {3, 5, . . . ,K}, for odd K (the choice
of Ω is dictated by the facts that k = 1 reduces to 1-TSP, whereas Proposition
1 does not hold for even k):
k∗ = arg max
k=3,5,...,K
τˆTSM(G
+,∗
k , G
−,∗
k ) (3.24)
where
τˆTSM(G
+,∗
k , G
−,∗
k ) =
δˆTSM(G
+,∗
k , G
−,∗
k )
σˆTSM(G
+,∗
k , G
−,∗
k )
=
Eˆ
[
med
j∈G+,∗k
Rj − med
i∈G−,∗k
Ri
∣∣∣∣Y = 1
]
− Eˆ
[
med
j∈G+,∗k
Rj − med
i∈G−,∗k
Ri
∣∣∣∣Y = 0
]
√√√√V̂ar( med
j∈G+,∗k
Rj − med
i∈G−,∗k
Ri
∣∣∣∣Y = 0
)
+ V̂ar
(
med
j∈G+,∗k
Rj − med
i∈G−,∗k
Ri
∣∣∣∣Y = 1
) .
(3.25)
Notice that τˆTSM is defined directly by replacing (3.4) into (3.7) and (3.14), and
then using (3.16). In particular, it does not use the approximation in (3.13).
Finally, the optimal context is given by Θ∗ = (G+,∗k∗ , G
−,∗
k∗ ).
For both KTSP and TSM classifiers, the step-wise process to perform the
maximization of the criterion, c.f. Eqs. (3.19) and (3.23), does not need to be
restarted as k increases, since the sub-optimal contexts are nested (by contrast,
the method in Tan et al. [2005] employed cross-validation to choose k∗). The
detailed context selection procedure for KTSP and TSM classifiers is given in
pseudo-code in the Appendix.
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3.4. Error Rates
In this section, we discuss the choice of the threshold t used in (3.1). The sen-
sitivity is defined as P (f(X) = 1 | Y = 1) and the specificity is defined as
P (f(X) = 0 | Y = 0). We are interested in controlling both, but trade-offs
are inevitable. The choice of which phenotype to designate as 1 is application-
dependent; often sensitivity is relative to the more malignant one and this is the
way we have assigned labels to the phenotypes. A given application may call for
emphasizing sensitivity at the expense of specificity or vice-versa. For example,
in detecting BRCA1 mutations, or with aggressive diseases such as pancreatic
cancer, high sensitivity is important, whereas for more common and less ag-
gressive cancers, such as prostate, it may be preferable to limit the number of
false alarms and achieve high specificity. In principle, selecting the appropriate
threshold t in (3.1) allows one to achieve a desired tradeoff. (A disadvantage
of TSP is the lack of a discriminant, and thus a procedure to adjust sensitiv-
ity and specificity.) It should be noted, however, that in practice estimating the
threshold on the training data can be difficult; moreover, introducing a non-zero
threshold makes the decision rule somewhat more difficult to interpret. As an
example, Figure 2 displays the ROC curve of the TSM classifier for the BRCA1
and Prostate 4 studies, together with thresholds achieving hypothetically de-
sired scenarios.
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Fig 2. ROC curves for TSM and two datasets. Left: BRCA1. With the indicated threshold, we
can achieve the sensitivity around 0.9 at the expense of specificity around 0.6. Right Prostate
4: The given threshold reaches 0.88 specificity at the expense of sensitivity around 0.55.
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Parameters Discriminant Parameter Selection
(Θk, k) g(X; Θk)
General Θk ⊂ {1, . . . , d} δ̂(Θk)= Ê(g(X; Θk)|Y =1)−Ê(g(X; Θk)|Y =0) Θ∗k= arg maxΘk δ̂(Θk)
σˆ(Θk) =
√
V̂ar (g|Y = 0) + V̂ar (g|Y = 1) k∗ = arg max
k
δ̂(Θ∗k)
σ̂(Θ∗
k
)
Examples
TSP Θ = (i, j) gTSP = I(Xi < Xj)− 12 Θ∗ = arg max(i,j)∈Θ ŝij
ŝij=P (Xi<Xj|Y =1)−P (Xi<Xj |Y =0)
KTSP Θk = {i1, j1, . . . , ik, jk} gKTSP =
k∑
r=1
[I(Xir < Xjr )− 12 ] Θ∗k = arg maxΘk
k∑
r=1
ŝirjr
TSM Θk = G
+
k
⋃
G−k gTSM = med
j∈G+
k
Rj − med
i∈G−
k
Ri
G−k = {i1, . . . , ik} Ri :rank of gene i in G+k ∪G−k Θ∗k ≈ arg maxΘk
∑
i∈G−
k
,j∈G+
k
ŝij
G+k = {j1, . . . , jk}
Table 2
Summary of rank discriminants: First column: the rank-based classifiers considered in
this paper. Second column: the structure of the context Θk, the genes appearing in the
classifier; For kTSP and TSM, Θk contains 2k genes. Third column: the form of the rank
discriminant; the classifier is f(X) = I(g(X) > 0). Fourth column: the selection of the
context from training data. For a fixed k we select Θk to maximize δˆ, and then choose k to
maximize δˆ normalized by σˆ.
4. Experimental Results
A summary of the rank-based disriminants developed in the preceeding sections
is given in Table 2. We learned each one for each of the datasets listed in Table 1.
Among an abundance of proposed methods for high-dimensional data classifi-
cation (e.g., Bradley and Mangasarian [1998],Zhang et al. [2006],Marron et al.
[2007]), we chose two of the most effective and popular choices for predicting
phenotypes from expression data: PAM (Tibshirani et al. [2002]), which is a
form of LDA, and SVM-RFE (Guyon et al. [2002]), which is a form of linear
SVM.
Generalization errors are estimated with cross-validation, specifically aver-
aging the results of ten repetitions of ten-fold CV, as recommended in Braga-
Neto and Dougherty [2004] and Hastie et al. [2001]. Despite the inaccuracy
of small-sample cross-validation estimates (Braga-Neto and Dougherty [2004]),
this suffices to obtain the broad perspective on relative performance across many
different datasets.
Estimated classification rates are presented in Figure 3 and 4. The protocols
for training (including parameter selection) are given below. To reduce com-
putation, we filter the whole gene pool without using the class labels before
selecting the context for rank discriminants (TSP, KTSP and TSM). Although
a variety of filtering methods exist in the literature, such as PAM (Tibshirani
et al. [2002]), SIS (Fan and Lv [2008]), Dantzig selector (Candes and Tao [2007])
and the Wilcoxon-Rank test (Wilcoxon [1945]), we simply use an average signal
filter: select the 4000 genes with highest mean rank (across both classes). In par-
ticular, there is no effort to detect “differentially expressed” genes. In this way
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we minimize the influence of the filtering method in assessing the performance
of rank discriminants.
• TSP: The single pair which maximizing sij over all pairs in the 4000
filtered genes, breaking scoring ties if necessary with the secondary score
proposed in Xu et al. [2005].
• KTSP: The k disjoint pairs maximizing sij over all pairs in the 4000
filtered genes with the same tie-breaking method. The number of pairs k
is determined via Algorithm 1, within the range k = 3, 5, . . . , 9, avoiding
ties in voting. Notice that k = 1 is excluded so that KTSP cannot reduce
to TSP. We tried also k = 3, 5, . . . , 49 and the cross-validated accuracies
changed insignificantly.
• TSM: The context is chosen from the top 4000 genes by the greedy se-
lection procedure described in Algorithm 2. The size of the two sets for
computing the median rank is selected in the range k = 3, 5, 7, 9 (pro-
viding a unique median and thereby rendering Proposition 1 applicable).
We also tried k = 3, 5, . . . , 49 and again the change in the cross-validated
accuracies were insignificant.
• SVM-RFE: We learned two linear SVMs using SVM-RFE: one with ten
genes and one with a hundred genes. No filtering was applied, since SVM-
RFE itself does that. Since we found that the choice of the slack variable
barely changes the results, we fix C = 0.1. (In fact, the data are linearly
separable in nearly all loops.) Only the results for SVM-RFE with a hun-
dred genes are shown since it was almost 3% better than with ten genes.
• PAM: We use the automatic filtering mechanism provided by Tibshirani
[2011]. The prior class likelihoods were set to 0.5 and all other parameters
were set to default values. The most important parameter is the threshold;
the automatic one chosen by the program results in relatively lower accu-
racy than the other methods (84.00%) on average. Fixing the threshold
and choosing the best one over all datasets only increases the accuracy by
one percent. Instead, for each dataset and each threshold, we estimated
the cross-validated accuracy for PAM and report the accuracy of the best
threshold for that dataset.
Figure 3 and 4, and Table 3 show the performance estimates of the clas-
sifiers across 21 datasets in box plot format. The averages are: TSP (85.59%),
KTSP (90.07%), TSM (88.97%), SVM-RFE (89.92%) and PAM(88.19%). The
differences in the averages among methods do not appear substantial, with the
possible exception of TSP, which lags behind the others.
There are however clearly significant variations in performance within in-
dividual datasets. In order to examine these variations at a finer scale, possi-
bly revealing trends to support practical recommendations, recall that for each
dataset and each method, we did ten repetitions of ten-fold cross-validation,
resulting in one hundred trained classifiers and estimated rates (on the left-out
subsets), which were averaged to provide a single cross-validated classification
rate. The notch-boxes for each dataset and method are plotted in figure 3 and
figure 4. As is commonly done, any two methods will be declared to be “tied” on
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DataSet TSP TSM KTSP SVM PAM
Colon 88/88 86/88 87/86 87/73 83/81
BRCA1 71/75 90/75 88/77 68/88 39/82
CNS 41/79 81/88 67/93 52/86 77/79
DLBCL 98/97 96/95 96/88 97/91 72/100
Lung 92/97 97/99 94/100 95/100 97/100
Marfan 82/93 89/90 88/96 99/93 88/87
Crohn’s 89/90 92/91 92/96 100/100 93/98
Sarcoma 83/78 88/89 93/91 97/94 93/100
Squamous 89/88 88/85 99/92 94/95 94/95
GCM 81/73 88/77 90/75 94/80 95/94
Leukemia 1 90/85 97/94 97/93 98/97 95/89
Leukemia 2 96/96 100/93 100/96 100/96 73/88
Leukemia 3 98/98 97/99 97/98 100/100 96/99
Leukemia 4 92/94 95/98 96/97 99/97 77/92
Prostate 1 95/93 89/96 90/95 91/95 89/91
Prostate 2 68/68 76/79 76/83 68/79 77/74
Prostate 3 97/79 99/90 99/83 99/100 98/100
Prostate 4 77/61 87/70 86/79 92/62 66/85
Prostate 5 97/99 97/98 95/99 100/99 99/100
Breast 1 82/90 82/91 85/91 77/88 95/98
Breast 2 83/82 73/89 75/87 71/86 86/88
Table 3
Sensitivity/specificity for different classification methods. Overall accuracy is calculated as
the average of sensitivity and specificity.
a given dataset if the notches overlap; otherwise, i.e., if the notches are disjoint,
the “winner” is taken to be the one with the larger median.
First, as concerns the three RIC classifiers, and using the notch test, KTSP
slightly out-performs TSM, which in turn out-performs TSP. More specifically,
KTSP has accuracy superior to both others on ten datasets. In terms of TSP vs.
TSM, KTSP outperforms on three datasets, vice-versa on one dataset and they
tie on all others. Moreover, TSM outperforms TSP on nine datasets and vice-
versa on two datasets. As a result, if accuracy is the dominant concern, we rec-
ommend KTSP among the RIC classifiers, whereas if simplicity, transparancey
and links to biological mechanism are important, one might prefer TSP. Com-
parisons with non-RIC methods (see below) we will then be based on KTSP,
although substituting TSM does not lead to appreciably different conclusions.
Second, as concerns PAM vs. SVM, SVM performs better on six datasets and
PAM on three datasets. Hence, in the remainder of this section we will compare
KTSP with SVM. We emphasize that the comparison between PAM and SVM
is on our particular datasets, using our particular measures of performance,
namely cross-validation to estimate accuracy and the notch test for pairwise
comparisons, and we are not by any means recommeding SVM over PAM in
general.
Third, in comparing KTSP and SVM, whereas their overall performance
statistics are almost identical, trends do emerge based on sample size, which
is obviously an important parameter and especially useful here because it varies
considerably among our datasets (Table 1). To avoid fine-tuning, we only con-
sider a coarse and somewhat arbitrary quantization into three categories: “small,”
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“medium” and “large” datasets, defined, respectively, by fewer than 100 (total)
samples (twelve datasets), 100-200 samples (five datasets) and more than 200
samples (four datasets). On small datasets, KTSP outperforms SVM on four
datasets and never vice-versa; for medium datasets each outperforms the other
on one of the five datasets; and SVM outperforms KTSP on three out of four
large datasets and never vice versa.
Another criterion is sparsity: the number of genes used by TSP is always two
and by SVM-RFE is always one hundred. Averaged across all datasets and loops
of cross-validation, KTSP uses 12.5 genes, TSM uses 10.16 genes, and PAM uses
5771 genes.
Finally, we performed an experiment to roughly gauge the variability in se-
lecting the genes in the support of the various classifiers. Taking advantage of
the fact that we train 100 different classifiers for each method and dataset,
each time with approximately the same number of examples, we define a “con-
sistency” measure for a pair of classifiers as the average support overlap over
all distinct pairs of runs. That is, for any given dataset and method, and any
two loops of cross validation, let S1 and S2 be the supports (set of selected
genes) and define the overlap as |S1∩S2||S1∪S2| . This fraction is then averaged over all
100(99)/2 pairs of loops, and obviously ranges from zero (no consistency) to one
(consistency in all loops). Whereas in 16 of the 21 datasets KTSP had a higher
consistency score than SVM, the more important point is that in both cases the
scores are low in absolute terms, which coheres with other observations about
the enormous variations in learned genes signatures.
5. Discussion and Conclusions
What might be a “mechanistic interpretation” of the TSP classifier, where the
context consists of only two genes? In Price et al. [2007], a reversal between the
two genes Prune2 and Obscurin is shown to be an accurate test for separating
GIST and LMS. Providing an explanation, an hypothesized mechanism, is not
straightforward, although it has been recently shown that both modulate RhoA
activity (which controls many signaling events): a splice variant of Prune2 is
reported to decrease RhoA activity when over-expressed and Obscurin contains
a Rho-GEF binding domain which helps to activate RhoA (Funk [2012]).
Generically, one of the most elementary regulatory motifs is simply A inhibits
B (denoted A a B). For example, A may be constutively “on” and B constu-
tively “off” after development. Perhaps A is a transcription factor or involved
in methylation of B. In the normal phenotype we see A expressed but perhaps
A becomes inactivated in the cancer phenotype, resulting in the expression of
B, and hence an expression reversal from normal to cancer. Still more generally,
a variety of regulatory feedback loops have been identified in mammals. For
instance, an example of a bi-stable loop is shown below.
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Fig 5. A bi-stable feedback loop. Molecules A1, A2 (resp. B1, B2) are from the same species,
for example two miRNAs (resp., two mRNAs). Letters in boldface indicate an “on” state.
Due to the activation and suppression patterns depicted in Figure 5, we might
expect P (XA1 < XA2 |Y = 0) P (XA1 < XA2 |Y = 1) and P (XB1 < XB2 |Y =
0)  P (XB1 < XB2 |Y = 1). Thus there are two expression reversals, one
between the two miRNAs and one, in the opposite direction, between the two
mRNAs. Given both miRNA and mRNA data, we might then build a classifier
based on the these two switches. For example, the rank discriminant might
simply be 2TSP, the number of reversals observed. It is in this sense that we have
argued that expression comparisons may provide an elementary building block
for a connection between rank-based decision rules and potential mechanism.
We have reported extensive experiments with classifiers based on expression
comparisons with different diseases and microarray platforms and compared the
results with other methods which usually use significantly more genes. No one
classifier, whether within the rank-based collection or between these and other
methods such as SVM and PAM , is uniformly dominant. The most appropri-
ate one to use is likely to be problem-dependent. Moreover, until much larger
datasets become available, it will be difficult to obtain highly accurate estimates
of generalization errors. What does seem apparent is that our results support the
conclusions reached in earlier studies (Dudoit et al. [2002], Braga-Neto [2007],
Wang [2012], Simon et al. [2003]) that simple classifiers are usually competitive
with more complex ones with microarray data and limited samples. This has
important consequences for future developments in functional genomics since
one key thrust of “personalized medicine” is an attempt to learn appropriate
treatments for disease subtypes, which means sample sizes will not necessarily
get larger and might even get smaller. Moreover, as attention turns increas-
ingly towards treatment, potentially mechanistic characterizations of statistical
decisions will become of paramount importance for translational medicine.
Appendix
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Testing the Assumptions (A1), (A2). Recall that the empirical score
δTSM is maximized by maximizing the expression in (3.13) from Proposition 1,
provided that two assumptions (A1) and (A2) are satisfied. The first assumption
was investigated by with Fisher’s exact test to check if the events {Xi < Xj}
and {m− = i} are conditionally independent given Y . Because of symmetry,
checking the assumption for the event {m+ = j} is unnecessary. To check the
conditional independence assumption, we randomly chose a subset of genes G−
with random odd size. For each gene i ∈ G−, we chose a random gene j and
tested the hypothesis {Xi < Xj} and {m− = i} are independent given Y : we
formed the contingency table of the two random variables I(Xi < Xj) and
I(m− = i), given the data from each class separately. We computed the p-
value for Fisher’s exact test for ten thousand random choices of G− and j. The
independence hypothesis was not rejected in nearly all cases. In fact, in all the
datasets except Prostate1, we observed p < 0.05 in fewer than than 3% of the
trials. (For Prostate1, the rate of rejection was five percent.)
The second assumption behind the criterion for choosing the context is that
the distribution of the indices of the medians is roughly uniform. One example is
illustrated in Table 4 for the full Sarcoma dataset using the selection procedure
in Algorithm 2 with the score in (3.11). The data are roughly consistent with
samples from the uniform distribution. (p ≈ 1 using χ2-test) Over our twenty
one datasets, the test of uniformity typically yields p-values higher than 0.1,
although p < 0.05 was observed in six of the datasets. Still, even in those cases,
we do not observe extreme concentration on a few pairs of indices.
X6 X7 X8 X9 X10
X1 .03 .01 .08 .04 .03
X2 .03 .00 .06 .05 .00
X3 .01 .04 .06 .06 .01
X4 .04 .06 .06 .04 .02
X5 .03 .08 .06 .07 .02
Table 4
Median distribution on Sarcoma. The genes in G1 (resp., G2) are labeled 1, ..., 5 (resp.,
6, ..., 10) for the optimal context. Shown is the percentage of samples for which each pair
assumes the median.
Proof of Proposition 1. First notice that, for any j ∈ G+k ∪G−k , we have
Rj =
∑
i∈G+k ∪G−k
I(Xj ≥ Xi) =
∑
i∈G+k
I(Xj ≥ Xi) +
∑
i∈G−k
I(Xj ≥ Xi) . (5.1)
Hence (assuming odd k),
med
i∈G+k
Ri =
∑
i∈G+k
I(Xm+ ≥ Xi) +
∑
i∈G−k
I(Xm+ ≥ Xi)
=
k + 1
2
+
∑
i∈G−k
I(Xm+ ≥ Xi)
(5.2)
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and
med
i∈G−k
Ri =
∑
i∈G+k
I(Xm− ≥ Xi) +
∑
i∈G−k
I(Xm− ≥ Xi)
=
∑
i∈G+k
I(Xm− ≥ Xi) + k + 12 .
(5.3)
Therefore,
E
[
med
i∈G+k
Ri − med
i∈G−k
Ri
∣∣∣∣Y = c
]
=
∑
i∈G−k
P (Xm+ ≥ Xi | Y = c)−
∑
i∈G+k
P (Xm− ≥ Xi | Y = c) ,
(5.4)
for c = 0, 1, so that the criterion (3.12) can be written as
δTSM(G
+
k , G
−
k ) =
∑
i∈G−k
(P (Xm+ ≥ Xi | Y = 1)− P (Xm+ ≥ Xi | Y = 0))
−
∑
i∈G+k
(P (Xm− ≥ Xi | Y = 1)− P (Xm− ≥ Xi | Y = 0)) .
(5.5)
But the smoothness conditions (A1) and (A2) allow us to write
P (Xm+ ≥ Xi | Y = c) =
∑
j∈G+k
P (Xj ≥ Xi | Y = c,m+ = j)P (m+ = j | Y = 1)
=
1
k
∑
j∈G+k
P (Xj ≥ Xi | Y = c)
(5.6)
and
P (Xm− ≥ Xi | Y = c) =
∑
j∈G−k
P (Xj ≥ Xi | Y = c,m− = j)P (m− = j | Y = 1)
=
1
k
∑
j∈G−k
P (Xj ≥ Xi | Y = c) ,
(5.7)
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Algorithm 1 KTSP Context Selection Algorithm. The context is initialized
with the TSP and the best pair of genes not in the current context is added at
each step. The maximum number of pairs of genes is K and the output is the
selected context Θ∗ ← {(i∗1, j∗1 ), . . . , (i∗k∗ , j∗k∗)}.
Calculate sˆij = Pˆ (Xi < Xj | Y = 1)− Pˆ (Xi < Xj | Y = 0) for all i, j
(i∗1, j
∗
1 ) = arg maxi,j sˆij {1-TSP is TSP}
k∗ ← 1, t∗ ← −1{Initialize with TSP }
for k = 2 . . .K do
(i∗k, j
∗
k) = arg max
i,j 6∈{i∗1 ,j∗1 ,...,i∗k−1,j∗k−1}
sˆij {Add the best available pair of genes.}
t← τˆKTSP((i∗1, j∗1 ), . . . , (i∗k, j∗k)) {τˆKTSP defined in (3.22)}
if t > t∗ and k ∈ {3, 5, . . .} then
t∗ ← t, k∗ ← k
end if{If the new odd k results in a better criterion, update k∗.}
end for
Θ∗ ← {(i∗1, j∗1 ), . . . , (i∗k∗ , j∗k∗ )} {Optimal context.}
for c = 0, 1. Substituting these back into (5.5), we obtain
δTSM(G
+
k , G
−
k ) =
1
k
∑
i∈G−k
∑
j∈G+k
(P (Xj ≥ Xi | Y = 1)− P (Xj ≥ Xi | Y = 0))
− 1
k
∑
j∈G−k
∑
i∈G+k
(P (Xj ≥ Xi | Y = 1)− P (Xj ≥ Xi | Y = 0))
=
1
k
∑
i∈G−k
∑
j∈G+k
(sij − sji)
=
2
k
∑
i∈G−k
∑
j∈G+k
sij ,
(5.8)
where we used the fact that sji = −sij . 
Pseudo-code for the KTSP and TSM classifiers. Please see the pseudo-
code in Algorithm 1 and Algorithm 2.
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Fig 3. Estimated classification accuracy for datasets predicting disease phenotypes. Classifiers
were learned for datasets D1,...,D11 and performance was estimated by the average of ten
runs of ten-fold cross validation. The box plots show the distribution of the 100 runs for
each dataset. The number written close to every box represents the estimated accuracy of the
classifier rate. Also, stars represent outliers.
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Fig 4. Estimated classification accuracy for datasets predicting disease phenotypes. Classifiers
were learned for datasets D12,...,D21 and the bottom diagram represents the average of the
accuracies across all data sets. As can be seen, almost all of them perform similarly with the
exception of TSP which lags the rest by 3%. On average, KTSP seems to perform with less
dispersion and a slightly larger median accuracy.
